Abstract
Direct oral anticoagulants have recently been recommended for non-valvular atrial fibrillation, but have rarely been studied in the field of cardiac surgery. We prospectively investigated the safety of edoxaban, a novel oral anticoagulant, for use in cardiac surgery patients with postoperative atrial fibrillation (POAF), which is the most common complication of cardiac surgery and can lead to stroke. The subjects were adult cardiac surgery patients with POAF who received oral edoxaban for 2 months in an open-label pilot study. The primary endpoint was cerebrovascular/bleeding events up to 2 months, while the secondary endpoints were hemoglobin, prothrombin time, and activated partial thromboplastin time. There were no cerebrovascular or bleeding events during edoxaban treatment and the test drug was not discontinued by any patient. There was no macroscopic hematuria and hemoglobin did not decrease, being significantly higher than the baseline level after 2 months. The prothrombin time was significantly prolonged from 1 week to 2 months and the activated partial thromboplastin time was significantly prolonged from 1 day to 2 months. Echocardiography detected pericardial effusion in 1 patient, but hemoglobin did not decrease and ...Continue Reading
References
Mar 31, 2009·The Journal of Thoracic and Cardiovascular Surgery·Akira SezaiKazutomo Minami
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators
Aug 4, 2012·The Journal of Thoracic and Cardiovascular Surgery·Akira SezaiAtsushi Hirayama
Aug 23, 2012·Circulation·Deborah SiegalAlex C Spyropoulos
Nov 21, 2013·The New England Journal of Medicine·Robert P GiuglianoUNKNOWN ENGAGE AF-TIMI 48 Investigators
Apr 1, 2014·Circulation·Craig T JanuaryUNKNOWN ACC/AHA Task Force Members
Jun 27, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·UNKNOWN JCS Joint Working Group
Dec 17, 2014·Circulation·Benjamin A SteinbergUNKNOWN Outcomes Registry for Better Informed Treatment of Atrial Fibrillation Investigators and Patients
May 20, 2015·Thrombosis Research·D M Adcock, R Gosselin
Aug 10, 2015·The Journal of Thoracic and Cardiovascular Surgery·Akira SezaiMotomi Shiono
Oct 21, 2015·American Journal of Surgery·Eric AndersonCornelius Dyke
Citations
Oct 4, 2018·Scandinavian Journal of Clinical and Laboratory Investigation·Andreas HillarpTomas L Lindahl
Mar 23, 2019·Expert Review of Cardiovascular Therapy·Carlos Escobar CervantesVivencio Barrios
Apr 24, 2019·Journal of Cardiac Surgery·Pey-Jen YuAlan Hartman
Sep 2, 2017·Expert Opinion on Drug Safety·Matthias Hammwöhner, Andreas Goette
Sep 11, 2019·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Yousef RezaeiSaeid Hosseini
Nov 20, 2020·Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia·Akira SezaiMasashi Tanaka
Apr 6, 2021·The Annals of Pharmacotherapy·Erica H Z WangRicky Turgeon
Jun 4, 2021·Clinical Therapeutics·Dareen M KanaanRhynn Malloy